| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $14.45B | +5.4% |
| Gross profit | $14.45B | — |
| Operating income | $3.17B | — |
| Net income | $2.69B | -9.4% |
| Gross margin | 100.0% | Net margin 18.6% |
| Segment | Revenue | Share |
|---|---|---|
| U.S.Commercial Division | $7.69B | 53.2% |
| International Commercial Division | $5.23B | 36.2% |
| Global Hospital And Biosimilars Division | $1.24B | 8.6% |
| Item | Amount | % of revenue |
|---|---|---|
| SG&A | $2.96B | 20.5% |
| Tax & other | $0.48B | 3.3% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
PCG ・ PM ・ PSX ・ PNW ・ PNC ・ PPG ・ PPL ・ PFG ・ PG ・ PGR ・ PLD ・ PRU
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies